View in EDS

First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin.

Saved in:
Bibliographic Details
Title: First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin.
Authors: Iacovelli, R.1 (AUTHOR) Roberto.iacovelli@policlinicogemelli.it, Ciccarese, C.1 (AUTHOR), Brunelli, M.2 (AUTHOR), Battelli, N.3 (AUTHOR), Buttigliero, C.4 (AUTHOR), Caserta, C.5 (AUTHOR), Buti, S.6,7 (AUTHOR), Santini, D.8,9 (AUTHOR), Carella, C.10 (AUTHOR), Galli, L.11 (AUTHOR), Verri, E.12 (AUTHOR), Ermacora, P.13 (AUTHOR), Merler, S.14 (AUTHOR), Masini, C.15 (AUTHOR), De Vivo, R.16 (AUTHOR), Milesi, L.17 (AUTHOR), Spina, F.18 (AUTHOR), Rizzo, M.19 (AUTHOR), Sperduti, I.20 (AUTHOR), Fornarini, G.1,21 (AUTHOR)
Source: Annals of Oncology. Nov2022, Vol. 33 Issue 11, p1179-1185. 7p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 159846582
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Iacovelli%2C+R%2E%22">Iacovelli, R.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> Roberto.iacovelli@policlinicogemelli.it</i><br /><searchLink fieldCode="AR" term="%22Ciccarese%2C+C%2E%22">Ciccarese, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brunelli%2C+M%2E%22">Brunelli, M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Battelli%2C+N%2E%22">Battelli, N.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Buttigliero%2C+C%2E%22">Buttigliero, C.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Caserta%2C+C%2E%22">Caserta, C.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Buti%2C+S%2E%22">Buti, S.</searchLink><relatesTo>6,7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Santini%2C+D%2E%22">Santini, D.</searchLink><relatesTo>8,9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Carella%2C+C%2E%22">Carella, C.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Galli%2C+L%2E%22">Galli, L.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Verri%2C+E%2E%22">Verri, E.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ermacora%2C+P%2E%22">Ermacora, P.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Merler%2C+S%2E%22">Merler, S.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Masini%2C+C%2E%22">Masini, C.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22De+Vivo%2C+R%2E%22">De Vivo, R.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Milesi%2C+L%2E%22">Milesi, L.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Spina%2C+F%2E%22">Spina, F.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rizzo%2C+M%2E%22">Rizzo, M.</searchLink><relatesTo>19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sperduti%2C+I%2E%22">Sperduti, I.</searchLink><relatesTo>20</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fornarini%2C+G%2E%22">Fornarini, G.</searchLink><relatesTo>1,21</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Nov2022, Vol. 33 Issue 11, p1179-1185. 7p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=159846582
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2022.07.011
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 1179
    Titles:
      – TitleFull: First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Iacovelli, R.
      – PersonEntity:
          Name:
            NameFull: Ciccarese, C.
      – PersonEntity:
          Name:
            NameFull: Brunelli, M.
      – PersonEntity:
          Name:
            NameFull: Battelli, N.
      – PersonEntity:
          Name:
            NameFull: Buttigliero, C.
      – PersonEntity:
          Name:
            NameFull: Caserta, C.
      – PersonEntity:
          Name:
            NameFull: Buti, S.
      – PersonEntity:
          Name:
            NameFull: Santini, D.
      – PersonEntity:
          Name:
            NameFull: Carella, C.
      – PersonEntity:
          Name:
            NameFull: Galli, L.
      – PersonEntity:
          Name:
            NameFull: Verri, E.
      – PersonEntity:
          Name:
            NameFull: Ermacora, P.
      – PersonEntity:
          Name:
            NameFull: Merler, S.
      – PersonEntity:
          Name:
            NameFull: Masini, C.
      – PersonEntity:
          Name:
            NameFull: De Vivo, R.
      – PersonEntity:
          Name:
            NameFull: Milesi, L.
      – PersonEntity:
          Name:
            NameFull: Spina, F.
      – PersonEntity:
          Name:
            NameFull: Rizzo, M.
      – PersonEntity:
          Name:
            NameFull: Sperduti, I.
      – PersonEntity:
          Name:
            NameFull: Fornarini, G.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: Nov2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 33
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1